Glucose– tag –
-
FiberSense AG Secures CE Mark for Groundbreaking 28-Day Optical CGM System, Targeting European Market Entry
PR Newswire (The Storm Media経由) Switzerland, EU Overview Swiss medtech firm FiberSense AG has obtained CE Mark approval for its continuous glucose monitoring (CGM) system as a Class IIb medical device under EU Regulation 2017/745. This... -
Ultrahuman Launches M2 Live Metabolic Health Platform in U.S., Integrating Abbott’s OTC Lingo CGM for Prescription-Free Glucose Tracking
PR Newswire USA Overview Ultrahuman, a smart ring manufacturer, has launched 'M2 Live,' a metabolic health platform in the U.S. that integrates data from Abbott's over-the-counter (OTC) continuous glucose monitor (CGM) 'Lingo.' Available... -
Medtronic Enhances MiniMed 780G AID System with New CGM Sensors and Launches Screenless MiniMed Flex Pump
diaTribe.org USA Overview Medtronic has introduced two new continuous glucose monitor (CGM) sensors for its MiniMed 780G automated insulin delivery (AID) system in the U.S.: the 6-day Simplera Sync and the 15-day Instinct (based on Abbot... -
FDA Clears Dexcom’s Stelo, First Over-the-Counter CGM for Non-Insulin-Using Children Aged Two and Older
FDA USA Overview The U.S. FDA has approved Dexcom's Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM) for children aged two and older who do not use insulin. This expansion significantly ... -
Century Therapeutics Unveils CNTY-813 iPSC-Derived Islet Replacement Preclinical Data at ADA 2026: Demonstrates Durable Glucose Control, Immune Evasion, and Scalable Manufacturing, IND Filing Expected Q4 2026
BioSpace (via GlobeNewswire) USA Overview Century Therapeutics presented new preclinical data for its iPSC-derived islet replacement therapy, CNTY-813, at the ADA 2026 Scientific Sessions. The data demonstrated durable glucose control, i... -
Next-Gen Process Analytics and QC Elevate Bioprocessing Efficiency: Real-Time Raman Probes Enable Continuous Glucose and Lactate Monitoring
Technology Networks UK Overview A Technology Networks article highlights how next-generation Process Analytical Technology (PAT) and industrial Quality Control (QC) testing significantly enhance biopharmaceutical manufacturing efficiency... -
Nano-Micro Letters Reviews Polymer-Based Flexible Wireless Sensors, Evaluating Applications for Epidermal, Subcutaneous, and Short-term Implantable Health Monitoring
Nano-Micro Letters China Overview A review in Nano-Micro Letters provides a system-level perspective on polymer-based flexible wireless sensors designed for epidermal, subcutaneous, and short-term implantable health monitoring. The revie... -
Implantable and Non-Invasive Continuous Health Sensors Advance Personalized Medicine with AI and Wireless Tech, Enabling Up to 1-Year Subcutaneous Deployment
ELE Times India Overview Continuous health sensors, encompassing both implantable and non-invasive wearables, are fundamentally transforming modern medicine. Continuous glucose monitors (CGMs) for diabetes management stand out as one of ... -
Nanomaterial Enhancements Dramatically Boost Hydrogel Sensor Performance, Achieving 93% Accuracy in Wearable pH Meter
MDPI (Polymers) Switzerland Overview A recent review reports significant advancements in hydrogel-based sensors, with electrical, mechanical, and sensing performances dramatically improved through the incorporation of nanomaterials like ... -
FDA Approves Finger-Prick Free Dexcom Stelo and Abbott Libre CGMs, Revolutionizing Metabolic Management for Non-Insulin Users
Mattioli 1885 / GoodRx USA Overview The FDA has approved continuous glucose monitoring (CGM) systems like Dexcom Stelo and Abbott's Lingo (and FreeStyle Libre series), eliminating the need for traditional finger-prick tests and marking a...
